Welcome to CDC Stacks | Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease - 44526 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease
  • Published Date:
    Sep 2016
  • Source:
    J Occup Environ Med. 58(9):855-860.


Public Access Version Available on: September 01, 2017 information icon
Please check back on the date listed above.
Details:
  • Pubmed ID:
    27414009
  • Pubmed Central ID:
    PMC5339739
  • Description:
    Objective

    Beryllium workers may better understand their genetic susceptibility to chronic beryllium disease (CBD) expressed as population-based prevalence, rather than odds ratios from case-control studies.

    Methods

    We calculated CBD prevalences from allele-specific DNA sequences of 853 workers for Human Leukocyte Antigen (HLA)-DPB1 genotypes and groups characterized by number of E69-containing alleles and by calculated surface electronegativity of HLA-DPB1.

    Results

    Of 18 groups of at least 10 workers with specific genotypes, CBD prevalence was highest, 72.7%, for the HLA-DPB1*02:01:02/DPB1*17:01 genotype. Population-based grouped genotypes with two E69 alleles wherein one allele had −9 surface charge had a beryllium sensitization (BeS) of 52.6% and a CBD prevalence of 42.1%.

    Conclusions

    The high CBD and BeS prevalences associated with −9-charged E69 alleles and two E69s suggest that workers may benefit from knowing their genetic susceptibility in deciding whether to avoid future beryllium exposure.

  • Document Type:
  • Collection(s):
  • Funding:
    CC999999/Intramural CDC HHS/United States
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: